The authors examine the risks of extractables and leachables and present solutions that emphasize the importance of a strategic multi-prong approach.
Piet Christiaens
Advertisement
Piet Christiaens is scientific director at Nelson Labs Europe.
Articles by Piet Christiaens
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
2
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
3
Welcome to CPHI Frankfurt 2025
4
Regulatory Challenges for Global Manufacturing of Vaccines
5
